Neonc Technologies (NTHI) Soars 900% in IPO Debut

On March 31, 2025, Neonc Technologies (NTHI) opened at $0.30 in pre-market trading.

Neonc Technologies recently went public with an IPO on March 26, 2025, issuing 2,100,000 shares at $25.00 per share. This significant event marks a new chapter for the company, which is now listed on the NASDAQ under the ticker symbol NTHI.

The company has appointed Dr. Steven L. Giannotta, a renowned figure in the biotechnology industry, to a key position. This strategic move is expected to enhance the company's research and development capabilities, potentially driving future growth and innovation.

Neonc's NEO100 and NEO212 therapeutics are currently in Phase II human clinical trials, advancing under FDA Fast-Track and Investigational New Drug (IND) status. This progress indicates the company's commitment to developing groundbreaking treatments, which could significantly impact the biotech sector and investor sentiment.